Atea Pharmaceuticals
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $0 | $0 |
Gross Profit | -104 | -104 | ||
EBITDA | -38,922 | -37,202 | -46,916 | -69,702 |
EBIT | -39,026 | -37,306 | -47,020 | -69,806 |
Net Income | -33,543 | -31,151 | -40,522 | -63,169 |
Net Change In Cash | 0 | 0 | 0 | 0 |
Free Cash Flow | -30,397 | -23,035 | -42,202 | -39,865 |
Cash | 64,696 | 98,463 | 243,394 | 160,910 |
Basic Shares | 84,463 | 84,422 | 84,253 | 83,916 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $0 | $0 | $192,180 | $351,367 |
Gross Profit | -70,090 | -260 | 351,367 | |
EBITDA | -192,950 | -119,593 | -130,390 | 138,406 |
EBIT | -120,009 | -130,650 | 138,377 | |
Net Income | -168,385 | -135,956 | -115,909 | 121,190 |
Net Change In Cash | 0 | 0 | 192,180 | 351,367 |
Cost of Revenue | -85,544 | |||
Free Cash Flow | -135,499 | -85,395 | -122,925 | -87,009 |
Cash | 64,696 | 143,823 | 646,709 | 764,375 |
Basic Shares | 84,264 | 83,389 | 83,245 | 88,249 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-12-31 | -$0.40 |
2024-09-30 | -$0.37 |
2024-06-30 | -$0.48 |
2024-03-31 | -$0.75 |
